Barrow Neurological Foundation Announces Three New Trustees
Catherine Ivy, Adam Levin, and Jonathan Levine join the Foundation’s Board
Barrow Neurological Foundation is pleased to announce Catherine Ivy, Adam Levin, and Jonathan Levine as members of its Board of Trustees. Board members provide governance to fulfill the Foundation’s mission to be the catalyst for donors’ passion by providing the resources for Barrow Neurological Institute to achieve its mission of saving human lives through innovative treatment, groundbreaking research, and educating the next generation of the world’s leading neurologists, neurosurgeons, and neuroscientists.
“We are extremely fortunate to have Catherine Ivy, Adam Levin, and Jonathan Levine on our Board of Trustees,” said Katie Cobb, President of Barrow Neurological Foundation. “Catherine is a pioneer and change agent in the field of brain cancer research and her experience in establishing and guiding non-profit enterprises will be invaluable to the evolution of Barrow Neurological Foundation. Adam is one of the foremost experts on data security and privacy in the nation, and his mastery of these complex technologies will serve our Foundation and the Institute well as data becomes more integral to high-quality patient care, along with the gold standard of stewardship. Jonathan brings a wealth of experience to our Board, including a fundamental understanding of brain development, consumer awareness generation, and overall business strategies that are essential in building the Barrow brand worldwide.”
Catherine Ivy is the founder and president of the Ben and Catherine Ivy Foundation, the largest private funder of brain cancer research in the world. Since 2005, Ms. Ivy has led the efforts of the Ivy Foundation in funding over $120 million in glioma research. After undertaking an international search, the Ivy Foundation chose Barrow Neurological Institute to lead a large translational project that would bring immediate impact to patients with brain cancer. In 2018, the Ivy Brain Tumor Center at Barrow opened as the largest Phase 0 clinical trials program in the world. Ms. Ivy continues to lead the Ivy Foundation in supporting brain cancer research to develop better treatments that offer long-term survival and higher quality of life for patients.
Adam Levin is the founder of CyberScout, one of the largest identity theft education and resolution, identity management, and data breach response companies. He is also the co-founder of Credit.com, a credit education and consumer advocacy company. Mr. Levin was formerly the Director of the New Jersey Division of Consumer Affairs. A nationally recognized expert on cyber security, privacy, identity theft, fraud, and personal finance, he is the author of Swiped: How To Protect Yourself In A World Full of Scammers, Phishers, And Identity Thieves and co-hosts the podcast “What the Hack with Adam Levin.” Mr. Levin serves as president of his family foundation, the Philip and Janice Levin Foundation. He has served on the Boards of the Foundation for Art and Preservation in Embassies, The School of American Ballet, and the Tel Aviv Foundation.
Jonathan Levine is the president of Keim, Inc. and the general partner of Levine Investments L.P. Prior to his position at Keim, Inc., Mr. Levine worked at Outdoor Systems Advertising in real estate development and sales. In 1996, he co-founded American Outdoor Advertising, an outdoor advertising company that owns and operates billboards in Arizona, California, and Nevada. In 2016, he became a co-owner of Pacific Outdoor Advertising. Mr. Levine serves as a director of his family foundation, the William S. and Ina Levine Foundation. In 1999, his father, William Levine, established a fund to endow the Ina Levine Brain Tumor Center at Barrow.
The Board of Trustees, which comprises community members who serve on a voluntary basis, governs Barrow Neurological Foundation. Initial Board appointments are for one year, with reappointment up for three consecutive three-year terms.